High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Shubbar, Emman ^a   Helou, Khalil ^b   Kovács, Anikó ^c   Nemes, Szilárd ^b   Hajizadeh, Shahin ^c   Enerbäck, Charlotta ^d   Einbeigi, Zakaria ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA ACADEMY AT UNIVERSITY OF GOTHENBURG   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Breast cancer; Disease specific survival; GGH; Primary invasive breast cancer tumors; Prognostic factor; Recurrence free survival

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; FATTY ACID AMIDASE; GAMMA GLUTAMYL HYDROLASE; PROGESTERONE RECEPTOR; PROTEIN TAF5L; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; DOWN REGULATION; FATTY ACID AMIDE HYDROLASE GENE; GAMMA GLUTAMYL HYDROLASE GENE; GENE; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOG RANK TEST; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PIRIN GENE; PRIMARY TUMOR; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TAF5L GENE; UNIVARIATE ANALYSIS; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; AMIDOHYDROLASES; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CARRIER PROTEINS; CHI-SQUARE DISTRIBUTION; CYTOPLASM; DISEASE-FREE SURVIVAL; FEMALE; GAMMA-GLUTAMYL HYDROLASE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NUCLEAR PROTEINS; P300-CBP TRANSCRIPTION FACTORS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; TATA-BINDING PROTEIN ASSOCIATED FACTORS; TIME FACTORS; TRANSCRIPTION FACTOR TFIID; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84873030996     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-47     Document Type: Article

References (39)

1. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, et al. Molecular portraits of human breast tumours. Nature 2000, 406(6797):747-752. 10.1038/35021093, 10963602.
2. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001, 98(19):10869-10874. 10.1073/pnas.191367098, 58566, 11553815.
3. Karlsson E, Delle U, Danielsson A, Olsson B, Abel F, Karlsson P, Helou K. Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer. BMC Cancer 2008, 8:254. 10.1186/1471-2407-8-254, 2559847, 18778486.
4. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415(6871):530-536. 10.1038/415530a, 11823860.
5. Pollard C, Nitz M, Baras A, Williams P, Moskaluk C, Theodorescu D. Genoproteomic mining of urothelial cancer suggests {gamma}-glutamyl hydrolase and diazepam-binding inhibitor as putative urinary markers of outcome after chemotherapy. Am J Pathol 2009, 175(5):1824-1830. 10.2353/ajpath.2009.090155, 2774049, 19815704.
6. Thors L, Bergh A, Persson E, Hammarsten P, Stattin P, Egevad L, Granfors T, Fowler CJ. Fatty acid amide hydrolase in prostate cancer: association with disease severity and outcome, CB1 receptor expression and regulation by IL-4. PLoS One 2010, 5(8):e12275. 10.1371/journal.pone.0012275, 2924377, 20808855.
7. Miyazaki I, Simizu S, Okumura H, Takagi S, Osada H. A small-molecule inhibitor shows that pirin regulates migration of melanoma cells. Nat Chem Biol 2010, 6(9):667-673. 10.1038/nchembio.423, 20711196.
8. Taniwaki M, Daigo Y, Ishikawa N, Takano A, Tsunoda T, Yasui W, Inai K, Kohno N, Nakamura Y. Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer. Int J Oncol 2006, 29(3):567-575.
9. Galivan J, Ryan TJ, Chave K, Rhee M, Yao R, Yin D. Glutamyl hydrolase. pharmacological role and enzymatic characterization. Pharmacol Ther 2000, 85(3):207-215. 10.1016/S0163-7258(99)00063-7, 10739875.
10. Zhao R, Goldman ID. Resistance to antifolates. Oncogene 2003, 22(47):7431-7457. 10.1038/sj.onc.1206946, 14576850.
11. Bertino JR. Karnofsky memorial lecture. Ode to methotrexate. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 1993, 11(1):5-14.
12. Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 2003, 3(5):330-338. 10.1038/nrc1074, 12724731.
13. Li WW, Waltham M, Tong W, Schweitzer BI, Bertino JR. Increased activity of gamma-glutamyl hydrolase in human sarcoma cell lines: a novel mechanism of intrinsic resistance to methotrexate (MTX). Adv Exp Med Biol 1993, 338:635-638. 10.1007/978-1-4615-2960-6_131, 7508171.
14. de Groot J, Sontheimer H. Glutamate and the biology of gliomas. GLIA 2011, 59(8):1181-1189. 10.1002/glia.21113, 3107875, 21192095.
15. Prickett TD, Samuels Y. Molecular pathways: dysregulated glutamatergic signaling pathways in cancer. Clinical cancer research: an official journal of the American Association for Cancer Research 2012, 18(16):4240-4246.
16. McKinney MK, Cravatt BF. Structure and function of fatty acid amide hydrolase. Annu Rev Biochem 2005, 74:411-432. 10.1146/annurev.biochem.74.082803.133450, 15952893.
17. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (New York, NY) 1992, 258(5090):1946-1949.
18. Guzman M, Sanchez C, Galve-Roperh I. Control of the cell survival/death decision by cannabinoids. Journal of molecular medicine (Berlin, Germany) 2001, 78(11):613-625.
19. Wendler WM, Kremmer E, Forster R, Winnacker EL. Identification of pirin, a novel highly conserved nuclear protein. J Biol Chem 1997, 272(13):8482-8489. 10.1074/jbc.272.13.8482, 9079676.
20. Baldwin AS. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996, 14:649-683. 10.1146/annurev.immunol.14.1.649, 8717528.
21. Dechend R, Hirano F, Lehmann K, Heissmeyer V, Ansieau S, Wulczyn FG, Scheidereit C, Leutz A. The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators. Oncogene 1999, 18(22):3316-3323. 10.1038/sj.onc.1202717, 10362352.
22. Nakatani Y. [Histone-like TAFs within the PCAF histone acetylase complex]. Tanpakushitsu kakusan koso Protein, nucleic acid, enzyme 1998, 43(14):2079-2086.
23. Schiltz RL, Nakatani Y. The PCAF acetylase complex as a potential tumor suppressor. Biochim Biophys Acta 2000, 1470(2):M37-M53.
24. Kim HS, Moon HG, Han W, Yom CK, Kim WH, Kim JH, Noh DY. COX2 overexpression is a prognostic marker for Stage III breast cancer. Breast Cancer Res Treat 2012, 132(1):51-59. 10.1007/s10549-011-1521-3, 21533532.
25. Kowalski PJ, Rubin MA, Kleer CG. E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast cancer research: BCR 2003, 5(6):R217-R222. 10.1186/bcr651, 314411, 14580257.
26. Helou K, Wallenius V, Qiu Y, Ohman F, Stahl F, Klinga-Levan K, Kindblom LG, Mandahl N, Jansson JO, Levan G. Amplification and overexpression of the hepatocyte growth factor receptor (HGFR/MET) in rat DMBA sarcomas. Oncogene 1999, 18(21):3226-3234. 10.1038/sj.onc.1202658, 10359528.
27. Petersson S, Shubbar E, Enerback L, Enerback C. Expression patterns of S100 proteins in melanocytes and melanocytic lesions. Melanoma Res 2009, 19(4):215-225. 10.1097/CMR.0b013e32832c6358, 19521263.
28. Chen DT, Nasir A, Venkataramu C, Fulp W, Gruidl M, Yeatman T. Evaluation of malignancy-risk gene signature in breast cancer patients. Breast Cancer Res Treat 2010, 120(1):25-34. 10.1007/s10549-009-0357-6, 2808422, 19306088.
29. He P, Varticovski L, Bowman ED, Fukuoka J, Welsh JA, Miura K, Jen J, Gabrielson E, Brambilla E, Travis WD, et al. Identification of carboxypeptidase E and gamma-glutamyl hydrolase as biomarkers for pulmonary neuroendocrine tumors by cDNA microarray. Hum Pathol 2004, 35(10):1196-1209. 10.1016/j.humpath.2004.06.014, 15492986.
30. Baggott JE, Heimburger DC, Krumdieck CL, Butterworth CE. Folate conjugase activity in the plasma and tumors of breast-cancer patients. Am J Clin Nutr 1987, 46(2):295-301.
31. O'Connor BM, Rotundo RF, Nimec Z, McGuire JJ, Galivan J. Secretion of gamma-glutamyl hydrolase in vitro. Cancer Res 1991, 51(15):3874-3881.
32. Longo GS, Gorlick R, Tong WP, Lin S, Steinherz P, Bertino JR. gamma-Glutamyl hydrolase and folylpolyglutamate synthetase activities predict polyglutamylation of methotrexate in acute leukemias. Oncol Res 1997, 9(5):259-263.
33. Place AE, Jin Huh S, Polyak K. The microenvironment in breast cancer progression: biology and implications for treatment. Breast cancer research: BCR 2011, 13(6):227. 10.1186/bcr2912, 3326543, 22078026.
34. Heaphy CM, Griffith JK, Bisoffi M. Mammary field cancerization: molecular evidence and clinical importance. Breast Cancer Res Treat 2009, 118(2):229-239. 10.1007/s10549-009-0504-0, 19685287.
35. Roman-Perez E, Casbas-Hernandez P, Pirone JR, Rein J, Carey LA, Lubet RA, Mani SA, Amos KD, Troester MA. Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients. Breast cancer research: BCR 2012, 14(2):R51. 10.1186/bcr3152, 3446385, 22429463.
36. Licciulli S, Luise C, Scafetta G, Capra M, Giardina G, Nuciforo P, Bosari S, Viale G, Mazzarol G, Tonelli C, et al. Pirin inhibits cellular senescence in melanocytic cells. Am J Pathol 2011, 178(5):2397-2406. 10.1016/j.ajpath.2011.01.019, 3081152, 21514450.
37. An J, Sun JY, Yuan Q, Tian HY, Qiu WL, Guo W, Zhao FK. Proteomics analysis of differentially expressed metastasis-associated proteins in adenoid cystic carcinoma cell lines of human salivary gland. Oral Oncol 2004, 40(4):400-408. 10.1016/j.oraloncology.2003.09.014, 14969819.
38. Ideker T, Thorsson V, Ranish JA, Christmas R, Buhler J, Eng JK, Bumgarner R, Goodlett DR, Aebersold R, Hood L. Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 2001, 292(5518):929-934. 10.1126/science.292.5518.929, 11340206.
39. Cox B, Kislinger T, Emili A. Integrating gene and protein expression data: pattern analysis and profile mining. Methods 2005, 35(3):303-314. 10.1016/j.ymeth.2004.08.021, 15722226.